All Type of News
Kang to accept third term
Kang Shin-ho, the incumbent chairman of the Federation of Korean Industries, expressed his willingness to accept another term.
Kang, chairman of Korea's top pharmaceutical company Dong-A, said on January 30 that if...
Pharmaceutical exports top $1.29 billion in 2006
Korea posted $1.29 billion in its drug export in 2006, up 13 percent compared with $1.15 billion a year earlier, while pharmaceutical imports in the same period surged to $4.4 billion, according to the Korea Pha...
Doctors reject new medical law
The Ministry of Health and Welfare's new medical rules, including introduction of a hybrid clinic of Western and Oriental medicines and easing barriers to joining the profession, have faced vehement opposition from th...
38 drug companies to raise class lawsuit on bio test fraud.
The KFDA took the 3rd administrative measure against the drugs, a registration cancellation, on charge of their bio equivalent test fraud, and 38 drug companies related with this problem at once raised a class lawsuit...
Skin softeners, tooth pastes to be classified into quasi-drug
Some OTC products, such as skin softeners, tooth pastes and nicotine-free cigarettes, will be newly designated as a quasi-drug, according to the newly revised law.
In order for customers to freely purchase these it...
GMP for medical device manufacturers required from May.
The good manufacturing practice (GMP) for the medical device industries will be legally required starting from May 31, including the new comers.
The KFDA gave a 3 year probation to the existing medical device manuf...
Chong Kun Dang's Yaila to go on sale next monthChong Kun Dang Pharmaceutical Co. said it will launch its new anti-impotence drug, Yaila (vardenafil) early February as another brandname of Bayer Healthcare's Levitra under str...
|
BGMP-endorsed companies top 129
A total of 129 companies were accredited with BGMP (bulk good manufacturing practice) at the end of last year, according to the Korea Food and Drug Administration.
The BGMP system was made compulsory from 2002 and ...
Approval on GMP and BGMP remarkably shortened to 2 months.
So far the review on GMP and BGMP used to take about 6 months for a final KFDA approval but now it will be shortened to 2 months by administering it by each different product. According to the new regulation, th...
KPMA, NHIC raise battle for insurance drugs' price comparison
The Korea Pharmaceutical Manufacturers Association (KPMA) and the National Health Insurance Corporation (NHIC) are clashing head-on over the KPMA's report that Korea's top 500-drug prices covered by the national healt...
